Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KS › Kansas City › NPI 1649259656
Hospital

University of Kansas Hospital Authority

University of Kansas Hospital Authority was paid $9.11M by Medicaid between Jan 2018 and Nov 2024, across 371 billing codes. Its largest line is 96110, Developmental screening, with scoring and documentation, per standardized instrument — 17% of everything it billed.

33Billing provider infoUNIVERSITY OF KANSAS HOSPITAL AUTHORITY
KANSAS CITY, KS 66160
33aNPI1649259656assigned 01/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.11M
24GClaims762,425
24DCodes billed371
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Kansas

Rank by total paid#4 of 48
Median peer was paid$461K
This provider vs. median20×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201875,322$1.26M
201981,470$1.05M
2020106,598$1.17M
2021129,544$1.33M
2022137,292$1.60M
2023143,494$1.71M
2024incomplete88,705$1.00M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96110 Developmental screening, with scoring and documentation, per standardized instrument 17% 48,354 46,556 $1.51M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.7% 10,164 9,264 $881K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 7.4% 35,205 33,823 $672K
90460 Immunization administration through 18 years of age via any route, first or only component 6.3% 14,123 13,997 $570K
80053 Comprehensive metabolic panel 6.1% 50,387 39,036 $555K
90472 Immunization administration, each additional vaccine (list separately) 5.4% 15,344 15,016 $488K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.9% 179,443 163,607 $449K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.7% 54,520 42,291 $432K
92551 3.9% 62,778 60,479 $358K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.4% 4,674 4,234 $308K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.4% 3,734 3,513 $218K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.1% 10,119 8,789 $189K
359 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.0% 3,371 $183K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.8% 4,557 $161K
90378 1.2% 94 $112K
J0585 Injection, onabotulinumtoxina, 1 unit 1.1% 356 $105K
X4003 1.1% 989 $97K
99173 1.0% 62,403 $95K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.0% 2,667 $92K
81001 <1% 6,507 $77K
96127 <1% 6,674 $60K
76820 <1% 1,651 $56K
X4011 State-specific procedure code <1% 142 $53K
64483 <1% 547 $49K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 14,937 $48K
G0378 Hospital observation service, per hour <1% 475 $45K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 774 $45K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,607 $45K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 14,359 $44K
76819 Fetal biophysical profile; without non-stress testing <1% 1,275 $38K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 68 $37K
Y7506 <1% 473 $35K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 20 $33K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 736 $33K
67028 Intravitreal injection of a pharmacologic agent <1% 546 $31K
93325 <1% 559 $28K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 225 $25K
96361 Intravenous infusion, hydration; each additional hour <1% 1,343 $24K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 235 $23K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 7,585 $21K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 129 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 565 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 565 $20K
90480 <1% 1,062 $20K
80061 Lipid panel <1% 1,656 $19K
84484 <1% 2,241 $19K
87631 <1% 178 $18K
90677 <1% 1,313 $16K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 480 $16K
93321 <1% 448 $16K
96161 <1% 9,498 $15K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 522 $15K
84443 Thyroid stimulating hormone (TSH) <1% 1,461 $15K
93304 <1% 208 $14K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 157 $11K
81025 <1% 545 $11K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 3,675 $11K
71045 Radiologic examination, chest; single view <1% 852 $10K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 217 $10K
85027 <1% 1,590 $10K
90670 <1% 7,256 $9K
73630 <1% 729 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 409 $9K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 204 $9K
71250 <1% 86 $8K
86833 <1% 114 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 734 $7K
93296 <1% 626 $7K
93299 <1% 76 $7K
86832 <1% 116 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 393 $7K
59025 Fetal non-stress test <1% 395 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 777 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 307 $7K
82784 <1% 1,073 $7K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 41 $6K
70450 Computed tomography, head or brain; without contrast material <1% 127 $6K
87497 <1% 86 $6K
93976 <1% 196 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 284 $6K
90686 <1% 20,128 $6K
83735 <1% 1,873 $6K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 542 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 741 $6K
71046 Radiologic examination, chest; 2 views <1% 336 $5K
86780 <1% 390 $5K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 30 $5K
0081A <1% 236 $5K
0071A <1% 190 $5K
J2469 Injection, palonosetron hcl, 25 mcg <1% 42 $5K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 132 $5K
0072A <1% 158 $5K
82105 <1% 716 $5K
83690 <1% 368 $5K
85610 <1% 1,803 $5K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 77 $5K
72082 <1% 108 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 388 $4K
64644 <1% 82 $4K
83655 <1% 356 $4K
20610 <1% 47 $4K
90474 <1% 790 $4K
82378 <1% 343 $4K
87081 <1% 580 $4K
82728 <1% 307 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 120 $4K
J2785 Injection, regadenoson, 0.1 mg <1% 44 $4K
84439 <1% 352 $4K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 50 $4K
92134 <1% 1,437 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 113 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 628 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 117 $3K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 12 $3K
76821 <1% 86 $3K
0124A <1% 134 $3K
0001A <1% 86 $3K
95117 <1% 672 $3K
96417 <1% 81 $3K
83880 <1% 253 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 75 $3K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 91 $3K
84165 <1% 803 $3K
96376 <1% 1,377 $3K
86850 <1% 455 $3K
76830 Ultrasound, transvaginal <1% 69 $3K
0173A <1% 108 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 365 $3K
94010 <1% 223 $3K
82607 <1% 216 $2K
43235 <1% 16 $2K
73610 <1% 198 $2K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 20 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,433 $2K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 27 $2K
96415 <1% 113 $2K
76775 <1% 69 $2K
70486 <1% 15 $2K
94726 <1% 77 $2K
87400 <1% 335 $2K
88142 <1% 124 $2K
95886 <1% 39 $2K
36591 <1% 454 $2K
73562 <1% 158 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 196 $2K
87340 <1% 206 $2K
83550 <1% 218 $2K
96401 <1% 42 $2K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 96 $2K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 19 $2K
73030 <1% 180 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 90 $2K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 18 $2K
73502 <1% 63 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 352 $1K
86140 <1% 345 $1K
94729 <1% 80 $1K
96910 <1% 240 $1K
83605 <1% 239 $1K
52000 <1% 13 $1K
82962 <1% 536 $1K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 14 $1K
87536 <1% 16 $1K
73130 <1% 94 $1K
87522 Neg quan hep c or qual rna <1% 136 $1K
86901 <1% 335 $1K
84100 <1% 922 $1K
0002A <1% 38 $1K
71275 Computed tomographic angiography, chest, with contrast material <1% 15 $1K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 58 $1K
90837 Psychotherapy session, about an hour <1% 467 $1K
95874 <1% 231 $1K
86803 <1% 116 $1K
87077 <1% 157 $1K
74018 <1% 93 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 778 $1K
85651 <1% 312 $1K
82570 <1% 403 $1K
83521 <1% 673 $1K
87210 <1% 257 $1K
73110 <1% 85 $1K
70491 <1% 13 $1K
90620 <1% 384 $996.61
86300 <1% 59 $988.53
86900 <1% 335 $987.73
77334 <1% 18 $974.95
87186 <1% 130 $961.92
86038 <1% 77 $960.19
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 299 $928.57
86235 <1% 15 $916.86
80197 <1% 482 $902.13
86762 <1% 139 $901.64
83516 <1% 90 $896.34
76818 <1% 23 $869.59
51798 <1% 16 $854.83
93017 <1% 60 $845.25
86255 <1% 70 $838.73
0082A <1% 31 $820.00
84702 <1% 103 $819.00
86481 <1% 17 $815.54
83540 <1% 227 $793.79
82565 <1% 253 $788.58
83615 <1% 166 $762.19
87420 <1% 79 $760.00
86161 <1% 87 $734.47
0054A <1% 33 $733.34
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 61 $733.25
51705 <1% 27 $728.18
80076 <1% 83 $717.54
93880 <1% 14 $712.70
90715 <1% 56 $707.59
81002 <1% 614 $700.23
96411 <1% 26 $686.36
83525 <1% 59 $686.35
J7030 Infusion, normal saline solution , 1000 cc <1% 770 $666.09
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 44 $660.82
92557 <1% 29 $647.93
83970 <1% 54 $620.87
90651 <1% 1,142 $620.24
80305 <1% 72 $606.66
82746 <1% 46 $602.90
97162 <1% 23 $592.63
72100 <1% 42 $588.98
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 53 $588.48
88307 <1% 33 $587.19
77336 <1% 29 $585.72
36415 Collection of venous blood by venipuncture <1% 3,054 $581.94
83883 <1% 547 $577.95
84550 <1% 527 $575.55
86706 <1% 64 $571.27
84153 <1% 57 $562.64
86704 <1% 63 $554.80
87070 <1% 96 $539.64
84156 <1% 330 $539.36
97602 <1% 16 $535.37
90847 Family psychotherapy with the patient present, 50 minutes <1% 13 $526.45
0004A <1% 22 $524.53
76536 <1% 34 $516.76
90647 <1% 4,476 $511.22
96367 <1% 42 $509.88
J7120 Ringers lactate infusion, up to 1000 cc <1% 576 $503.23
82951 <1% 35 $498.40
J3010 Injection, fentanyl citrate, 0.1 mg <1% 668 $491.13
82550 <1% 219 $436.20
85730 <1% 131 $433.88
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 15 $417.98
J3490 Unclassified drugs <1% 69 $400.92
83020 <1% 27 $391.60
86225 <1% 29 $379.80
92567 <1% 41 $367.88
73590 <1% 30 $352.64
81003 <1% 365 $352.27
85018 <1% 245 $344.77
97163 <1% 15 $333.80
97165 <1% 13 $324.67
0154A <1% 13 $320.00
72110 <1% 13 $319.55
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 653 $318.79
93923 <1% 27 $314.47
82977 <1% 101 $307.31
88342 <1% 64 $304.50
82043 <1% 91 $302.04
86361 <1% 15 $294.12
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 598 $287.93
J0780 Injection, prochlorperazine, up to 10 mg <1% 33 $285.50
94618 <1% 12 $273.08
86431 <1% 47 $271.57
J1170 Injection, hydromorphone, up to 4 mg <1% 289 $263.58
94760 <1% 91 $263.51
96381 <1% 13 $263.38
90656 <1% 1,964 $245.50
90734 <1% 597 $245.19
87102 <1% 34 $235.20
90473 <1% 73 $232.29
87147 <1% 42 $231.76
J7060 5% dextrose/water (500 ml = 1 unit) <1% 101 $230.08
73560 <1% 16 $225.54
80164 <1% 20 $224.64
82947 <1% 60 $221.28
0074A <1% 12 $201.04
J2704 Injection, propofol, 10 mg <1% 1,074 $191.89
76937 <1% 30 $184.33
85379 <1% 30 $183.73
J1650 Injection, enoxaparin sodium, 10 mg <1% 85 $182.78
J3475 Injection, magnesium sulfate, per 500 mg <1% 48 $181.44
84460 <1% 34 $177.60
90832 Psychotherapy session, about 30 minutes <1% 91 $176.74
72050 <1% 13 $175.84
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 197 $171.16
86039 <1% 13 $169.54
82150 <1% 30 $169.05
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 354 $165.73
86301 <1% 18 $164.32
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 379 $160.28
0003A <1% 14 $160.00
87184 <1% 31 $158.36
J2270 Injection, morphine sulfate, up to 10 mg <1% 58 $152.25
90707 <1% 1,000 $145.13
J0690 Injection, cefazolin sodium, 500 mg <1% 168 $141.22
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 386 $140.29
87799 <1% 18 $134.62
87205 <1% 43 $131.25
84403 <1% 13 $127.06
76882 <1% 64 $125.28
90716 <1% 967 $125.13
86790 <1% 20 $110.22
99152 <1% 40 $107.38
82330 <1% 23 $107.10
92250 <1% 40 $104.18
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 170 $100.97
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 13 $100.58
80047 <1% 15 $97.88
C9399 Unclassified drugs or biologicals <1% 28 $95.76
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 22 $93.47
81015 <1% 58 $92.67
87040 <1% 25 $87.55
82465 <1% 141 $87.26
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 64 $84.07
J1040 Injection, methylprednisolone acetate, 80 mg <1% 45 $81.34
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 41 $80.63
J1644 Injection, heparin sodium, per 1000 units <1% 118 $77.10
84520 <1% 14 $76.44
93290 <1% 13 $75.30
82247 <1% 20 $64.90
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 101 $62.56
82077 <1% 13 $62.16
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 1,219 $58.78
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 91 $55.04
81000 <1% 26 $52.44
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 129 $44.53
85045 <1% 14 $44.24
S0028 Injection, famotidine, 20 mg <1% 54 $39.38
90633 <1% 1,658 $37.55
J2060 Injection, lorazepam, 2 mg <1% 32 $36.34
84132 <1% 12 $25.20
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 17 $24.93
90380 <1% 13 $20.30
J3480 Injection, potassium chloride, per 2 meq <1% 18 $17.14
90723 <1% 4,880 $16.75
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 35 $6.30
90681 <1% 1,315 $4.44
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 26 $3.58
J1630 Injection, haloperidol, up to 5 mg <1% 43 $3.36
90696 <1% 98 $0.33
90700 <1% 93 $0.32
91321 <1% 246 $0.23
90710 <1% 50 $0.18
91322 <1% 44 $0.15
90685 <1% 13 $0.10
91318 <1% 70 $0.10
90381 <1% 13 $0.08
90461 0% 5,556 $0.00
A9505 Thallium tl-201 thallous chloride, diagnostic, per millicurie 0% 51 $0.00
90791 Psychiatric diagnostic evaluation 0% 58 $0.00
A9577 Injection, gadobenate dimeglumine (multihance), per ml 0% 112 $0.00
92015 Determination of refractive state 0% 167 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 30 $0.00
99382 0% 14 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 14 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 19 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 54 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 16 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 15 $0.00
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 0% 12 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 70 $0.00
C1769 Guide wire 0% 98 $0.00
V2632 Posterior chamber intraocular lens 0% 14 $0.00
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 0% 13 $0.00
G0008 Administration of influenza virus vaccine 0% 14 $0.00
90834 Psychotherapy session, about 45 minutes 0% 28 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 46 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPAGE, BOB (PRESIDENT & CEO)
Same official

Other billing entities under PAGE, BOB

Full network →
ProviderLocationPaid
University of Kansas Hospital AuthorityLenexa, KS$178K
University of Kansas Hospital AuthorityKansas City, KS$8K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.